Why Medtech Firms Need To Focus On Asia-Pacific
The medtech markets in Asia-Pacific have proved to be a hard nut to crack, but it would be premature to give up now.
A new research report from McKinsey & Company contends that the industry should redouble its efforts arguing that so far "medtech companies have approached Asia-Pacific's diverse and volatile markets cautiously" but "the region's underserved patients deserve a greater commitment."
A new research report from McKinsey & Company contends that the industry should redouble its efforts arguing that so far "medtech companies have approached Asia-Pacific's diverse and volatile markets cautiously" but "the region's underserved patients deserve a greater commitment."